Menu

Caught on Camera

Selected Images of the Day from the-scientist.com

Apr 1, 2018
The Scientist Staff

ASSASSIN FOR HIRE: Researchers in Switzerland have made progress in designing non-immune cells that can target and attack tumor cells, as shown in this artist's depiction.
Posted: November 13, 2017
RYO TACHIBANA
ROBODOCS: Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.
Posted: February 12, 2018
BAOQUAN DING AND HAO YAN
FISH AVATARS FOR CANCER: Zebrafish larvae transplanted with patients’ tumors (red) respond as their human donors do to chemotherapy.
Posted: September 11, 2017
RITA FIOR, CHAMPALIMAUD CENTRE FOR THE UNKNOWN

 

MANIPULATIVE MELANOMAS: Early-stage melanoma cells (gray) alter proteins in nearby skin cells (red) to create a favorable environment for cancer progression.
Posted: March 20, 2017
DEPARTMENT OF DERMATOLOGY, UNIVERSITY HOSPITAL ERLANGEN, TRANSLATIONSAL RESEARCH CENTER, GERMANY

 

SUNBURN: Melanoma (red and black on the left and right, respectively) in mouse melanocyte stem cells
Posted: October 20, 2017
HYEONGSUN MOON AND ANDREW WHITE, CORNELL UNIVERSITY
CANCER’S CRYSTAL BALLS: Testing treatments on mini tumors, such as these gastroesophageal cancer organoids, may save time in identifying which therapies work best.
Posted: February 22, 2018
GEORGE VLACHOGIANNIS

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.